Gilead Sciences Announces Second Quarter 2017 Dividend
May 02 2017 - 04:02PM
Business Wire
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the
company’s Board of Directors has declared a cash dividend of $0.52
per share of common stock for the second quarter of 2017. The
dividend is payable on June 29, 2017, to stockholders of record at
the close of business on June 16, 2017. Future dividends will be
subject to Board approval.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170502006379/en/
InvestorsGilead Sciences,
Inc.Robin Washington, 650-522-5688Sung Lee, 650-524-7792
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2023 to Mar 2024